Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy.

Sa Hamed1, Aj Sutherland-Smith, Jrm Gorospe

  • 1Research Center For Genetic Medicine, Children's National Medical Center, Washington DC, USA. hamed_sherifa@yahoo.com

Clinical Genetics
|June 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis.

Oncogene·2009
Same author

Myosin VI: a multifunctional motor.

Biochemical Society transactions·2004
Same author

Actin-dependent fluid-phase endocytosis in inner cortex cells of maize root apices.

Journal of experimental botany·2004
Same author

Unconventional myosins of the plant-specific class VIII: endocytosis, cytokinesis, plasmodesmata/pit-fields, and cell-to-cell coupling.

Cell biology international·2003
Same author

Myosin VI, a new force in clathrin mediated endocytosis.

FEBS letters·2001
Same author

Myosin-I nomenclature.

The Journal of cell biology·2001

Researchers screened the dystrophin gene in Becker muscular dystrophy patients. While 40% had mutations, many without mutations suggest other genetic issues affecting dystrophin quantity, impacting diagnosis.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neuromuscular Disorders

Background:

  • Becker muscular dystrophy is characterized by abnormal dystrophin.
  • Previous studies have not systematically investigated mutations in patients with normal quality but reduced quantity of dystrophin.
  • Understanding genotype-phenotype correlations is crucial for diagnosing muscular dystrophies.

Purpose of the Study:

  • To systematically screen the dystrophin gene in male patients with clinical suspicion of Becker muscular dystrophy.
  • To identify disease-causing mutations in the coding region, promoter, and 5'UTR of the dystrophin gene.
  • To investigate the genetic basis for reduced dystrophin quantity in mutation-negative patients.

Main Methods:

  • Automated sequence analysis of the complete coding region (11 kb) of the dystrophin gene from muscle biopsy RNA.

Related Experiment Videos

  • Sequencing of the gene promoter and 5'UTR (535 bp).
  • Quantitative multiplex fluorescence polymerase chain reaction (PCR) to assess dystrophin mRNA levels.

    • Main Results:

    • Seven disease-causing mutations (40%) were identified, including six novel mutations (missense, nonsense, small deletion, splice site).
    • Sixty percent (11/18) of patients with decreased dystrophin quantity showed no detectable mutation in the screened regions.
    • Quantitative PCR revealed normal dystrophin mRNA levels in most mutation-negative patients, though three showed reduced transcript levels, suggesting undetected genetic alterations.

    Conclusions:

    • Dystrophin protein studies require cautious interpretation in deletion-negative male muscular dystrophy patients.
    • The findings highlight the importance of considering transcriptional or translational defects beyond coding region mutations.
    • This study provides insights into structure/function and genotype/phenotype correlations in Becker muscular dystrophy.